Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-26

Clinical Trial Update: Reducing Postoperative Side Effect of Pregabalin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating pregabalin to reduce postoperative side effects after knee and hip arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Pain, Postoperative, Arthroplasty, Replacement, Knee | Phase 4 | Status: COMPLETED